ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 10.25p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 5526 to 5548 of 8900 messages
Chat Pages: Latest  224  223  222  221  220  219  218  217  216  215  214  213  Older
DateSubjectAuthorDiscuss
29/6/2017
09:54
Any thoughts on results today? Missed the presentation too ;-( D
dennisbergkamp
28/6/2017
17:22
I know good after bad etc.
yachtmaster2
28/6/2017
17:21
I bought a lot for a very small amount of money yesterday afternoon. Went through as a sell
yachtmaster2
28/6/2017
16:44
ReNeuron CFO Michael Hunt will be presenting to investors at the Proactive One2One Forum on the evening of 13th July in London. For details and registration, click here:
aim_trader
26/6/2017
13:45
Just bought a few at 1.799 pence at 13.35 for those interested to see if it later indicated it was a buy or a sell.I see plenty of potential upside medium term at this price.Here's to us Freddie and our pension fund. "Per Ardua Ad Astra" and chocks away!

Edit: appears to be indicated as a sell on all the share platforms I looked at just now.

algernon2
19/6/2017
19:36
Another piece of the jigsaw.I doubt it'll be catalyst for a sustained rise in the share price ....more likely to see it meander at 2p for while
audigger
19/6/2017
10:27
Huge potential here, but the market has been bitten to many times by jam tomorrow AIM companies. Although RENE have cash now, its not enough to take these therapies through to commercialisation, even if they do get approval. That's the problem with the share price. I'll continue on the side lines for the time being GLA.
johnb5
19/6/2017
09:47
FDA Approval is huge. Healthcare in the US is a huge business as its mainly private and paid out for through the huge insurance premiums they have to pay.

This really should be flying / taken out by a bigger player.

D.

dennisbergkamp
19/6/2017
09:30
It looks like everyone's on early hols across the entire market. Sleepy volumes everywhere.
small crow
19/6/2017
09:20
FDA Approval for their hRPC ophthamology formulation and still not much activity... Incredible!
dennisbergkamp
16/6/2017
11:34
Interesting news today that NHS has made a deal with Roche in order to bring very expensive cancer treatment into hospitals at undisclosed cost/dose. Lets hope it's the beginning of the beginning.
fredd1eboy
16/6/2017
11:13
All very depressing here..........need results to give impetus
chrisdgb
16/6/2017
09:21
Probably my fault as not used to advfn site. Will try to post on this one in future so long as I get replies from time to time. Best wishes. Freddie
fredd1eboy
16/6/2017
08:58
So many new threads . end up unused. This is the thread with the record
norbus
15/6/2017
18:04
Time.........Trade.....Volume...........Value
09:02:08...1.8125....2,500,000....£;45.31k

fredd1eboy
14/6/2017
08:53
Why would they sell (BoD)if there is the potential for significant upside? Whilst I don't pretend to understand the post placing fall, I also don't understand why the share price would be expected to be much higher at this stage. At some point people will buy in to the potential but clearly we ain't there yet.
audigger
14/6/2017
08:47
PIs deserve a lot more, having their savings de-risk the company for years ; sadly history with Chris Evans leaves a question mark. About 12 years ago, HM ER subscribed for shares at £2 and was taken out for pennies.
norbus
13/6/2017
22:59
How cheap is cheap?
alimo
13/6/2017
09:55
Looking more and more like being set up for a cheap takeout
norbus
12/6/2017
13:02
No academics them, but pocket liners
norbus
10/6/2017
08:21
Nor - couldn't agree more - these guy's (Bod) don't seem to understand the importance of the small investors. - With grants, seminars, and high flying dinners with large scale investors, they live in a la la world. We Pi's are just as much of the project as them and should be kept more informed! - Ignorant academics!
deutsch3
09/6/2017
10:52
Incredible share action; There has to be a desperate seller who had enough. Reneuron must surely know the selling camp. I do not understand why the company does not explain a price less than 40% of the major placing they had, when the company is said to have advanced its progress and added value.
norbus
08/6/2017
15:41
Cheers Verger. Best wishes. Fred
fredd1eboy
Chat Pages: Latest  224  223  222  221  220  219  218  217  216  215  214  213  Older

Your Recent History

Delayed Upgrade Clock